Document Detail

Can implant retention be recommended for treatment of infected TKA?
MedLine Citation:
PMID:  21080127     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Retention treatment is reportedly associated with lower infection control rates than two-stage revision. However, the studies on which this presumption are based depend on comparisons of historical rather than concurrent controls.
QUESTIONS/PURPOSES: We (1) asked whether the infection control rates, number of additional procedures, length of hospital stay, and treatment duration differed between implant retention and two-stage revision treatment; and (2) identified risk factors that can contribute to failure of infection control.
METHODS: We reviewed the records of 60 patients treated for 64 infected TKA from 2002 to 2007. Twenty-eight patients (32 knees) underwent débridement with retention of component, and 32 patients (32 knees) were treated with component removal and two-stage revision surgery. We determined patients' demographics, type of infection, causative organisms, and outcome of treatment. Mean followup was 36 months (range, 12-84 months).
RESULTS: Infection control rate was 31% in retention and 59% in the removal group after initial surgical treatment, and 81% and 91% at latest followup, respectively. Treatment duration was shorter in the retention group and there was no difference in number of additional surgeries and length of hospital stay. Type of treatment (retention versus removal) was the only factor associated with infection control; subgroup analysis in the retention group showed Staphylococcus aureus infection and polyethylene nonexchange as contributing factors for failure of infection control.
CONCLUSIONS: Although initial infection control rate was substantially lower in the retention group than the removal group, final results were comparable at latest followup. We believe retention treatment can be selectively considered for non-S. aureus infection, and when applied in selected patients, polyethylene exchange should be performed.
LEVEL OF EVIDENCE: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
Ho-Rim Choi; Fabian von Knoch; David Zurakowski; Sandra B Nelson; Henrik Malchau
Related Documents :
24886497 - Tick-borne pathogens and associated co-infections in ticks collected from domestic anim...
21175957 - The socio-ecology of zoonotic infections.
24103737 - Toxoplasma gondii and neospora caninum seroprevalence in dairy sheep and goats mixed st...
24652447 - On the life cycle and morphology of development stages of paraspiralatus sakeri gibbons...
5938817 - Studies of pplo infection. i. the production of cerebral polyarteritis by mycoplasma ga...
20477327 - Prevention of chronic pseudomonas aeruginosa infection in people with cystic fibrosis.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical orthopaedics and related research     Volume:  469     ISSN:  1528-1132     ISO Abbreviation:  Clin. Orthop. Relat. Res.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-04     Completed Date:  2011-05-12     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  0075674     Medline TA:  Clin Orthop Relat Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  961-9     Citation Subset:  AIM; IM    
Harris Orthopedic Laboratory, Department of Orthopedic Surgery, Massachusetts General Hospital, 55 Fruit Street, GRJ-1126, Boston, MA 02114, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Arthroplasty, Replacement, Knee / adverse effects*,  instrumentation
Chi-Square Distribution
Debridement* / adverse effects
Device Removal* / adverse effects
Infection Control* / methods
Kaplan-Meier Estimate
Knee Prosthesis / adverse effects*
Length of Stay
Logistic Models
Middle Aged
Odds Ratio
Patient Selection
Prosthesis Design
Prosthesis-Related Infections / diagnosis,  microbiology,  surgery*
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Precursor B cell lymphoblastic lymphoma presenting as a solitary bone tumor: a case report and revie...
Next Document:  Does trochanteric transfer eliminate the Trendelenburg sign in adults?